The Technical Analyst
Select Language :
Imara Inc [IMRA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Imara Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Imara Inc is listed at the  Exchange

15.96% $6.32

America/New_York / 23 feb 2023 @ 16:00


FUNDAMENTALS
MarketCap: 165.80 mill
EPS: 0.0600
P/E: 105.33
Earnings Date: May 04, 2023
SharesOutstanding: 26.23 mill
Avg Daily Volume: 0.116 mill
RATING 2023-02-27
A+
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Neutral
P/E: Neutral
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debtn/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 105.33 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
17.92x
Company: PE 105.33 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 6.00 - 6.64

( +/- 5.09%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-29 Lyssikatos Joseph P Sell 12 000 Stock Option (right to buy)
2023-12-29 Lyssikatos Joseph P Buy 12 000 Common Stock
2023-12-29 Lyssikatos Joseph P Sell 9 151 Common Stock
2023-12-29 Lyssikatos Joseph P Sell 2 849 Common Stock
2023-12-28 Patel Anish Sell 2 520 Common Stock
INSIDER POWER
83.59
Last 97 transactions
Buy: 15 631 291 | Sell: 878 871

Forecast: 01:40 - $5.15

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $6.32 (15.96% )
Volume 0.272 mill
Avg. Vol. 0.116 mill
% of Avg. Vol 233.72 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Imara Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Imara Inc

RSI

Intraday RSI14 chart for Imara Inc

Last 10 Buy & Sell Signals For IMRA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Imara Inc

IMRA

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
AMKTUSDMar 28 - 19:44220.76
CTXCUSDMar 28 - 19:44$0.475
ARUSDMar 28 - 19:43$41.56
MXUSDMar 28 - 19:41$4.29
C98USDMar 28 - 19:440.400
CVCUSDMar 28 - 19:44$0.219
XVSUSDMar 28 - 19:42$16.07
NEXOUSDMar 28 - 19:431.343
MATICUSDMar 28 - 19:43$1.002
BTCUSDMar 28 - 19:44$70 722

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.